203 related articles for article (PubMed ID: 24603967)
21. [Pathological observation and immunohistochemistry study of Type I, III, IV collagen in mitral valve and cardiac interstitium of rheumatic disease].
Fan H; Liu W; Yan P
Zhonghua Yi Xue Za Zhi; 1996 Mar; 76(3):183-6. PubMed ID: 8758424
[TBL] [Abstract][Full Text] [Related]
22. [Chronic rheumatic disease of the mitral valve: anatomopathological study of 73 surgically removed valves].
Thiene G; Bortolotti U; Scarin V; Valfrè C; D'Este R; Talenti E; Valente M; Pennelli N
Pathologica; 1982; 74(1029):99-110. PubMed ID: 7088596
[No Abstract] [Full Text] [Related]
23. Mitral valve geometry in paediatric rheumatic mitral regurgitation.
Yeong M; Silbery M; Finucane K; Wilson NJ; Gentles TL
Pediatr Cardiol; 2015 Apr; 36(4):827-34. PubMed ID: 25560735
[TBL] [Abstract][Full Text] [Related]
24. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Wang W; Zhang HT; Yang XL
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
[TBL] [Abstract][Full Text] [Related]
25. Planimetry of mitral valve stenosis in rheumatic heart disease by magnetic resonance imaging.
Lanjewar C; Ephrem B; Mishra N; Jhankariya B; Kerkar P
J Heart Valve Dis; 2010 May; 19(3):357-63. PubMed ID: 20583399
[TBL] [Abstract][Full Text] [Related]
26. [Discordance between mitral valve area (MVA) and pressure gradient in patients with mitral valve stenosis: mean transmitral valve gradient is a severity index or a tolerance index of severity of mitralss valve stenosis?].
Najih H; Arous S; Laarje A; Baghdadi D; Benouna MG; Azzouzi L; Habbal R
Pan Afr Med J; 2016; 25():75. PubMed ID: 28292038
[TBL] [Abstract][Full Text] [Related]
27. QT dispersion in patients with rheumatic mitral stenosis and its relation with echocardiographic findings and serum NT-proBNP levels.
Kılıçkesmez KO; Bulut G; Başkurt M; Coşkun U; Yıldız A; Küçükoğlu S
Turk Kardiyol Dern Ars; 2011 Apr; 39(3):183-90. PubMed ID: 21532293
[TBL] [Abstract][Full Text] [Related]
28. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
[TBL] [Abstract][Full Text] [Related]
29. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
30. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease.
Gölbaşý Z; Uçar O; Yüksel AG; Gülel O; Aydoğdu S; Ulusoy V
Eur J Heart Fail; 2004 Oct; 6(6):757-60. PubMed ID: 15542413
[TBL] [Abstract][Full Text] [Related]
31. Correlation of tissue selectin expression and hemodynamic parameters in rheumatic mitral valve disease.
Tokgözoglu L; Can I; Korkusuz P; Asan E; Ozer N; Demircin M
J Heart Valve Dis; 2006 Sep; 15(5):671-8. PubMed ID: 17044373
[TBL] [Abstract][Full Text] [Related]
32. Morphologic features of the normal and abnormal mitral valve.
Roberts WC
Am J Cardiol; 1983 Mar; 51(6):1005-28. PubMed ID: 6338691
[TBL] [Abstract][Full Text] [Related]
33. Assessment of insulin-like growth factor-1 (IGF-I) level in patients with rheumatic mitral stenosis.
Deveci OS; Yavuz B; Sen O; Deniz A; Ozkan S; Dal K; Ata N; Baser S; Akin KO; Kucukazman M; Beyan E; Ertugrul DT
Cardiol Young; 2015 Mar; 25(3):496-500. PubMed ID: 24625682
[TBL] [Abstract][Full Text] [Related]
34. Valvular heart disease: plasma B-type natriuretic peptide levels in patients with pure rheumatic mitral stenosis.
Uçar O; Bayar N; Karagöz A; Aydoğdu S
Acta Cardiol; 2012 Feb; 67(1):59-64. PubMed ID: 22455090
[TBL] [Abstract][Full Text] [Related]
35. Three-dimensional echocardiographic assessment before and after percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis.
Shashanka C; Rajasekhar D; Vanajakshamma V; Kumar ML
J Heart Valve Dis; 2013 Jul; 22(4):543-9. PubMed ID: 24224418
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.
Martos R; Baugh J; Ledwidge M; O'Loughlin C; Murphy NF; Conlon C; Patle A; Donnelly SC; McDonald K
Eur J Heart Fail; 2009 Feb; 11(2):191-7. PubMed ID: 19168518
[TBL] [Abstract][Full Text] [Related]
37. Systemic and local levels of fetuin-a in calcified mitral valves of rheumatic heart disease.
Mukhopadhyay S; Pandit BN; Saran RK; Mazumdar K; Yusuf J; Minhas HS; Trehan V; Tyagi S
J Heart Valve Dis; 2014 Jan; 23(1):55-65. PubMed ID: 24779329
[TBL] [Abstract][Full Text] [Related]
38. A clinicopathological study on the rheumatic valvular disease with a special reference to morphogenesis of valvular stenosis and insufficiency.
Okada R; Hazato N
Jpn Circ J; 1979 May; 43(5):458-62. PubMed ID: 470106
[No Abstract] [Full Text] [Related]
39. Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease.
Sagie A; Freitas N; Padial LR; Leavitt M; Morris E; Weyman AE; Levine RA
J Am Coll Cardiol; 1996 Aug; 28(2):472-9. PubMed ID: 8800128
[TBL] [Abstract][Full Text] [Related]
40. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest.
Tischler MD; Battle RW; Saha M; Niggel J; LeWinter MM
J Am Coll Cardiol; 1995 Jan; 25(1):128-33. PubMed ID: 7798489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
